18f fluorthanatrace
Small moleculeexperimentalImaging agent
Clinical trial activity
7 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02469129)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18f fluorthanatrace
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07114939 | Phase 1 | Oct 1, 2025 | University of Pennsylvania |
| NCT05636540 | Early Phase 1 (Phase 1) | Feb 1, 2023 | University of Pennsylvania |
| NCT04221061 | Early Phase 1 (Phase 1) | Dec 2, 2019 | University of Pennsylvania |
| NCT03492164 | Early Phase 1 (Phase 1) | Mar 20, 2018 | University of Pennsylvania |
| NCT03083288 | Phase 1 | Feb 22, 2017 | University of Pennsylvania |
| NCT02637934 | Phase 1 | Dec 1, 2015 | University of Pennsylvania |
| NCT02469129 | Early Phase 1 (Phase 1) | Mar 1, 2015 | Washington University in St. Louis |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Pennsylvania | Academic/Hospital | 6 | 6 | 1 | 2015 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1